Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Drug Repurposing Industry?

In recent times, the drug repurposing market has seen impressive growth. The market, which will rise from $34.12 billion in 2024 to $37.38 billion in 2025, is expected to grow at a mammoth compound annual growth rate (CAGR) of 9.5%. The surge in this period is a result of factors such as the increasing expense of developing new drugs, an increase in the number of drug failures during clinical trials, the growing demand for quicker drug approval processes, a rise in the availability of off-patent drugs, and significant increases in government and academic research funding.

In the coming years, substantial growth is anticipated for the drug repurposing market, which is projected to reach $53.42 billion by 2029 at a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this growth in the forecast period include a higher demand for therapies that are cost-effective, increased investment by pharmaceutical companies, growing partnerships between biotech firms, and broader applications in the fields of oncology and neurology. Key trends forecasted for this period include advancements in tools used for computational drug discovery, increased implementation of AI and ML in drug repurposing, innovations in predictive models for drug efficacy, incorporation of big data analytics in drug screening, and progress in the identification of biomarkers.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25758&type=smp

#Which Factors Are Currently Driving The Growth Of The Drug Repurposing Market?

The escalating occurrence of neurodegenerative diseases is anticipated to boost the expansion of the drug repurposing market in the future. Neurodegenerative diseases encompass a variety of conditions marked by the gradual degeneration or loss of neuronal structure or function, plus eventual neuronal death. The increasing instances of such diseases, like Alzheimer’s dementia, result from higher life expectancy, as age is a significant risk factor causing the steady deterioration of neuronal function over time. Drug repurposing aids patients suffering from neurodegenerative diseases by pinpointing existing medication with established safety profiles that can be rerouted to target disease channels, expediting the creation of efficient treatments. For example, in March 2023, the Alzheimer’s Association, a US-based volunteer health organization, stated that around 6.7 million US citizens aged 65 and older are battling Alzheimer’s dementia, with predictions suggesting this number will rise to 13.8 million by 2060. Hence, the ascendant prevalence of neurodegenerative diseases is fueling the growth of the drug repurposing market.

How Is The Global Drug Repurposing Market Structured In Terms Of Segments?

The drug repurposing market covered in this report is segmented –

1) By Type: Disease-Centric, Target-Centric, Drug-Centric

2) By Drug Molecules: Biologics, Small Molecule

3) By Therapeutic Area: Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Autoimmune Disorders

4) By Route Of Administration: Oral, Intravenous, Topical, Inhalation, Intramuscular

5) By End-User: Pharmaceutical Companies, Research And Academic Institutes, Contract Research Organizations

Subsegments:

1) By Disease-Centric: Phenotypic Screening, Epidemiological Analysis, Clinical Observation-Based Repurposing

2) By Target-Centric: Protein Target Modulation, Pathway Modulation, Biomarker-Based Targeting

3) By Drug-Centric: Off-Target Activity Identification, Structure-Based Drug Repositioning, Adverse Effect-Based Repurposing

What Trends Are Currently Influencing Growth In The Drug Repurposing Market?

Leading firms in the drug repurposing sector are honing their focus on the progression of sophisticated technology such as artificial intelligence-led drug-protein interaction modelling. This approach can expedite the discovery of alternative treatment paths for drugs already available in the market. These AI-led models employ expansive datasets, enhancing confidence and accuracy by predicting the interactions of drugs with proteins throughout the human proteome. Illustratively, in July 2025, the US healthcare firm Cosmos Health Inc. brought to the market Cloudscreen 2.0, a cutting-edge AI platform designed for drug repurposing. This progressive system can process datasets that are over 100 times larger than its predecessors, facilitating thorough analysis of drug-protein interactions. By using mutagenesis data and tools for disordered protein analysis, the platform focuses on targeting diseases such as cancer, diabetes, and obesity. Furthermore, with the application of graphics processing unit based cloud computing for scalable processing, the platform is set to be a game-changer in accelerating R&D for drug repurposing across various therapeutic sectors.

Who Are The Main Participants Shaping The Drug Repurposing Market Landscape?

Major companies operating in the drug repurposing market are F. Hoffmann-La Roche Ltd , International Business Machines Corporation (IBM), Bayer AG, Takeda Pharmaceutical Company Limited, Amgen Inc., Teva Pharmaceutical Industries Limited, Astellas Pharma Inc., UCB S.A., Eisai Co Ltd., Celltrion Inc., Alnylam Pharmaceuticals Inc., Evotec SE, BenevolentAI Limited, Insilico Medicine Inc., Cosmos Health Inc., Recursion Pharmaceuticals Inc., Pharnext S.A., Healx Ltd., Algernon Pharmaceuticals Inc., BioXcel Therapeutics Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-repurposing-global-market-report

Which Region Currently Holds The Largest Share In The Drug Repurposing Market?

North America was the largest region in the drug repurposing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug repurposing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25758&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model